Search alternatives:
significantly advanced » significantly enhanced (Expand Search), significantly enhance (Expand Search), significantly enhances (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
advanced decrease » advanced disease (Expand Search), advanced defense (Expand Search), advanced breast (Expand Search)
significantly advanced » significantly enhanced (Expand Search), significantly enhance (Expand Search), significantly enhances (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
advanced decrease » advanced disease (Expand Search), advanced defense (Expand Search), advanced breast (Expand Search)
-
2221
ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side.
Published 2025Subjects: -
2222
-
2223
-
2224
-
2225
-
2226
-
2227
-
2228
-
2229
-
2230
-
2231
-
2232
BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK<sup>mutants</sup>.
Published 2025Subjects: -
2233
-
2234
-
2235
Modeling the relationship between cancer level in hemolymph and MarBTN in tank eDNA.
Published 2025Subjects: -
2236
-
2237
-
2238
-
2239
Comparison of PLUS CYCLE<sup>®</sup> and video observations of hospitalized dogs.
Published 2025Subjects: -
2240